TRAX
First Tracks Biotherapeutics IncHealthcare · $1.9B market cap
Verdict
We can't put a fair value on TRAX right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.
Business quality
0 of 5 clear the 10% bar. What are the Big Five?
Follow TRAX
Track it on your watchlist and see the full analysis. Free.
Create a free accountInsider activity
Since Nov 1, 2026: no open-market purchases and 4 other filings (stock awards, tax withholding and similar). Why purchases matter
Other filings
Questions about TRAX
Are insiders buying TRAX?
Since Nov 1, 2026: no open-market purchases and 4 other filings (stock awards, tax withholding and similar).
How can I check TRAX's value myself?
Use the free Sticker Price calculator, already filled with TRAX's numbers. Change the growth, P/E or required return and see what you'd pay. Open the calculator →
Similar stocks · Biotechnology
About First Tracks Biotherapeutics Inc
First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.
Biotechnology
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of Nov 3, 2026. How the Payback Price works